Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kinesin-like protein KIF3A is a component of the kinesin-2 complex—a microtubule plus end-directed motor protein complex responsible for the anterograde transport of vesicles, protein complexes, and organelles along microtubules[1][2]. KIF3A, functioning as a heterotrimer with KIF3B or KIF3C and the associated protein KAP3, is essential for the formation and maintenance of cilia and flagella, regulates crucial signaling pathways (notably Wnt/β-catenin), and plays a prominent role in the development, differentiation, and homeostasis of a wide array of tissues[1][2][3][5]. Mutations or dysregulation of KIF3A are implicated in the pathogenesis of polycystic kidney disease, multiple solid tumor types, organ fibrosis, and developmental anomalies, making it a key candidate for research in ciliopathies and cancer biology[2][3][5]. Direct therapeutic targeting is not currently established, but its biological significance is well recognized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kinesin-like protein KIF3A (KIF3A).